SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001161697-21-000129
Filing Date
2021-02-25
Accepted
2021-02-25 17:30:50
Documents
3
Period of Report
2021-02-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT FOR 02-04-2021 form_8-k.htm 8-K 11732
2 PRESS RELEASE DATED FEBRUARY 11, 2021 ex_99-1.htm EX-99 4894
3 GRAPHIC angiosoma_logo.jpg GRAPHIC 10351
  Complete submission text file 0001161697-21-000129.txt   32208
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Filer) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-55072 | Film No.: 21682008
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences